本页面由Tiger Trade Technology Pte. Ltd.提供服务

Coherus Biosciences

1.03
-0.0400-3.74%
盘后:1.060.0300+2.91%19:30 EDT
成交量:103.67万
成交额:108.06万
市值:1.59亿
市盈率:-1.03
高:1.07
开:1.06
低:1.03
收:1.07
52周最高:2.62
52周最低:0.9740
股本:1.54亿
流通股本:1.36亿
量比:0.52
换手率:0.76%
股息:- -
股息率:- -
每股收益(TTM):-1.0011
每股收益(LYR):1.43
净资产收益率:-178.39%
总资产收益率:-30.52%
市净率:2.61
市盈率(LYR):0.72

数据加载中...

2023/06/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/06/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/06/15

重要事件披露

Form 8-K - Current report
2023/06/09

重要事件披露

Form 8-K - Current report
2023/05/31

重要事件披露

Form 8-K - Current report
2023/05/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/18

重要事件披露

Form 8-K - Current report
2023/05/15

重要事件披露

Form 8-K - Current report
2023/05/08

重要事件披露

8-K - Current report
2023/05/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/06

重要事件披露

8-K - Current report
2023/03/06

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/01/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/13

重要事件披露

8-K - Current report
2022/11/15

SEC问询函

CORRESP [Cover] - Correspondence